XCE Tirzepatide LY3298176 Peptide 99% Purity for Research Use

XCE Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research applications. This synthetic peptide demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.

The molecular mechanism of XCE Tirzepatide involves mimicking the actions of natural GIP at the GIP receptor while simultaneously activating GLP-1 receptors. This dual agonist approach produces more significant reductions in hyperglycemia through multiple pathways including enhanced β-cell responses, reduced glucagon secretion, suppressed appetite, and slowed gastric emptying.

Our XCE Tirzepatide is manufactured under strict pharmaceutical-grade conditions and supplied as lyophilized white powder with guaranteed purity >98% (typically >99%) as verified by HPLC analysis. Each batch is accompanied by comprehensive analytical documentation including mass spectrometry and purity certificates.

For research purposes only. Not for human consumption. Must be handled by qualified professionals in appropriate laboratory settings.